Acción 002198 GUANGDONG JIAYING PHARMACEUTICAL CO., LTD
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Guangdong Jiaying Pharmaceutical Co., Ltd

Acciones

002198

CNE1000008P1

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 08/05/2024 		Varia. Cinco días. Varia. 1 de enero.
6,4 CNY -2,59 % Gráfico intradía de Guangdong Jiaying Pharmaceutical Co., Ltd -2,29 % -12,09 %
26/04 Guangdong Jiaying Pharmaceutical Co., Ltd informa de los resultados de beneficios del primer trimestre finalizado el 31 de marzo de 2024 CI
26/04 Guangdong Jiaying Pharmaceutical Co., Ltd informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd. Approves Management Appointments
Resolutions on Supervisor Nomination by Guangdong Jiaying Venture Capital
Guangdong Jiaying Venture Capital Submits Proposals Related to Supervisor Nominations
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Guangzhou Taiping Enterprise Management Partnership (Limited Partnership) signed the Share Transfer Agreement to acquire 5% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 195 million.
Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Jiaying Pharmaceutical’s Profit Crashes 93% in 2021 Despite Revenue Growth
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Liu Libiao completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing.
Chen Shaobin completed the acquisition of 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong.
Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing for approximately CNY 210 million.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 002198
  4. Noticias Guangdong Jiaying Pharmaceutical Co., Ltd
  5. Otros idiomas